Avioq is a biotechnology, health care, and manufacturing company founded in 2007 with the slogan "Diagnostics for Life." Based in Research Triangle Park, North Carolina, it operates as an in vitro diagnostic medical device manufacturer and a contract development and manufacturing organization. Avioq's FDA licensed manufacturing facility and extensive R&D laboratories underscore its capability for innovation and production. The company's product range includes an FDA licensed HTLV-I/II assay and the FDA approved HIV Profile™ assay, designed for the confirmation and differentiation of individual antibodies to various gene products of HIV-1 and HIV-2. Avioq's strong value proposition lies in its expertise in navigating the regulatory process, exemplified by its FDA (BLA) licensed and ISO 13485:2106 certified manufacturing facility, which has undergone multiple inspections by regulatory authorities and external partners. With a focus on delivering products to market efficiently, Avioq offers services ranging from exploratory research to manufacturing, emphasizing its commitment to guiding clients past regulatory obstacles. The company's 25 years of experience in designing and developing medical diagnostic products further attests to its industry expertise.
There is no investment information
No recent news or press coverage available for Avioq.